Evidence map›Paper›PMID 41626449›Full record

ArticleACS omega2026

Preparation and Characterization of Coated ZnFe

Gulsum Caliskan, Sevil Ozer, Muhammad Irfan, Nurcan Dogan

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gulsum CaliskanDepartment of Physics, Gebze Technical University, 41400 Kocaeli, Turkey.
Sevil OzerTUBITAK National Metrology Institute (UME), 41400 Kocaeli, Turkey.ORCID https://orcid.org/0000-0002-0186-763X
Muhammad IrfanDepartment of Electronics Engineering, Gebze Technical University, 41400 Kocaeli, Turkey.
Nurcan DoganDepartment of Physics Engineering, Istanbul Technical University, 34469 Istanbul, Turkey.ORCID https://orcid.org/0000-0002-5689-2250

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic nanoparticles (MNPs) exhibit unique behaviors that make them appealing for a variety of clinical applications, including their use as tracer agents in magnetic particle imaging (MPI) and magnetic resonance imaging (MRI) systems, as heat generators in hyperthermia treatment, and in targeted drug delivery. We prepared maghemite cores (ZnFe

Identifiers

PMID41626449
PMCPMC12854523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.